Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis

By Ruys Anthony   Groot Koerkamp Bas   Wiggers Jimme   Klümpen Heinz-Josef   ten Kate Fiebo   Gulik Thomas  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 487-500

Springer Publishing Company

Access to resources Recommend Favorite

Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis

By Zhu Xiaolei   Stergiopoulos Kathleen   Wu Shenhong  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 9-17

Informa Healthcare

Access to resources Recommend Favorite

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma

By Mita M. M.   Poplin E.   Britten C. D.   Tap W. D.   Rubin E. H.   Scott B. B.   Berk L.   Rivera V. M.   Loewy J. W.   Dodion P.   Haluska F.   Sarantopoulos J.   Mita A.   Tolcher A.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1104-1111

Oxford University Press

Access to resources Recommend Favorite

Clinical Efficacy of Traditional Chinese Medicine as a Concomitant Therapy for Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

By Cho William   Chen Hai-yong  

Cancer Investigation, Vol. 27, Iss. 3, 2009-03 ,pp. : 334-344

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1145-1151

Science Publishers

Access to resources Recommend Favorite